Stereotactic radiosurgery for patients with "radioresistant" brain metastases.

  title={Stereotactic radiosurgery for patients with "radioresistant" brain metastases.},
  author={P D Brown and Cerise A Brown and Bruce E. Pollock and Deborah A Gorman and Robert L. Foote},
  volume={62 Suppl 2},
OBJECTIVE Our aim was to evaluate the efficacy of stereotactic radiosurgery (SRS) for the treatment of patients with brain metastases that have been determined to be "radioresistant" on the basis of histological examination. METHODS We reviewed the medical records of 41 consecutive patients who presented with 83 brain metastases from radioresistant primaries and subsequently underwent SRS. All patients were followed until death or for a median of 31 months after SRS. Tumor histologies… CONTINUE READING